NIQ Unveils Groundbreaking AI Tools for CPG Brands at FastCompany Innovation Festival 2024 Providing Human-Powered Insights at the Speed of AI
NielsenIQ (NIQ), the world’s leading global consumer intelligence company, announced two breakthroughs in artificial intelligence that further validate its leadership position. BASES AI and the CPG industry’s first large language model will help NIQ clients harness the power of responsible AI to drive innovation and grow market share. NIQ will also be speaking about AI trends in consumer buying intelligence and innovation at a panel on Thursday, September 19th at 2:20pm ET titled “Does AI Know What We Truly Want? How Synthetic Respondents Are Disrupting Product Innovation.”
BASES AI is a platform that uses consumer-permissioned data on consumption patterns across hundreds of thousands of households to mimic consumer behavior. The platform has access to data in real time, allowing it to create large panels of synthetic respondents to replicate trusted market research techniques and methodologies in a fraction of the time. Instead of days or weeks to gather human feedback, BASES AI can provide concept potential analysis in as little as 10 minutes. CPG companies can use these scores, as well as rich guidance on drivers of interest and uniqueness, to iterate on ideas ahead of final qualification with human consumers. The speed and quality of BASES AI means a larger volume of ideas can be evaluated while reducing overall innovation timelines. The release of BASES AI to Beta-testers in North America is coupled with the release of NIQ’s first CPG-specific language model, powering the advanced product segmentation capabilities of NIQ’s flagship Discover retail measurement platform. By leveraging NIQ’s database of 160 million products, the model outperforms public LLM models by over 7x in its ability to quickly and accurately code items. With access to new accelerators, the model will continue to evolve in both capability and sophistication, providing our clients with the Full View™ of their market and consumers through unparalleled insights.
“As the leading consumer intelligence player, we unlock mission-critical insights,” said Ramon Melgarejo,President, Strategic Analytics & Insights at NIQ. “In a fast-moving, consumer market focused on trend-based innovation, high-quality data is essential, and the ability to harness and extract insights from it will make all the difference in the world. These releases are the latest examples of how we are deploying our analytic horsepower across market-leading data sets to generate unparalleled insights that help CPG companies gain market share globally.”
NIQ’s world-class product suite brings the power of 2,000 engineers focused on analyzing $7.2 trillion in annual global consumer spending and data from more than 3,200 unique retailer partnerships. With an extensive set of data sources spanning multiple countries and thousands of data scientists focused on developing responsible AI-driven business intelligence solutions, NIQ remains the market leader in creating, maintaining, and driving new market share for clients.
BASES AI and NIQ’s CPG language model are the latest AI-powered solutions among NIQ’s vast existing product set. The company recently announced the integration of Consumer Panel and Retail measurement data on the NIQ Discover Platform, transforming the consumer insights landscape through advanced analytical models and always-on capabilities that deliver customizable client insights in response to their mission-critical queries. This cloud-based platform is one of several recent product enhancements including Microsoft Azure Marketplace integration; Tik Tok Shop collaboration; and NIQ Spaceman services for SPAR International partners globally. All of these announcements come on the heels of the company’s generative AI tool with global search, personalized data analysis, and recommendations for informed decision making, NIQ Ask Arthur, launched earlier this year.
“The drive to innovate and excel has been coded into NIQ’s DNA for over a century,” added Mohit Kapoor, Chief Technology Officer at NIQ. “Our completed integration of GfK creates a company with roughly 25,000 clients, regularly analyzing 2.48 trillion transactions a week. NIQ’s unique ability to offer the Full View™ – the world’s most complete and clear view of consumer buying behavior with AI-powered predictive analytics – allows us to experiment with an even larger number of parameters, uniquely positioning us to capture the market opportunity for the next 100 years.”
NIQ also regularly provides unique, proprietary insights across global consumer trends, including its latest SpendZ report, a comprehensive look at the spending trends of Gen Z and regular Consumer Outlook reports analyzing trends, behavior, and sentiment.
About NIQ
NielsenIQ (NIQ) is the world’s leading consumer intelligence company, delivering the most complete understanding of consumer buying behavior and revealing new pathways to growth. NIQ combined with GfK in 2023, bringing together the two industry leaders with unparalleled global reach. Today NIQ has operations in more than 95 countries covering 97% of GDP. With a holistic retail read and the most comprehensive consumer insights—delivered with advanced analytics through state-of-the-art platforms—NIQ delivers the Full View™.
For more information, please visit www.niq.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20240916757530/en/
Contacts
Media:
Sweta Patra
sweta.patra@nielseniq.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Vertex Announces US FDA Approval of ALYFTREK ™ , a Once-Daily Next-in-Class CFTR Modulator for the Treatment of Cystic Fibrosis20.12.2024 21:46:00 CET | Press Release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the U.S. Food and Drug Administration (FDA) has approved ALYFTREK (vanzacaftor/tezacaftor/deutivacaftor), a once-daily next-in-class triple combination cystic fibrosis transmembrane conductance regulator (CFTR) modulator for the treatment of cystic fibrosis (CF) in people 6 years and older who have at least one F508del mutation or another mutation in the CFTR gene that is responsive to ALYFTREK. See below for Important Safety Information, including a Boxed Warning. “ALYFTREK is our fifth CFTR modulator to secure FDA approval and represents another significant milestone in our journey to serially innovate and to improve the lives of people living with cystic fibrosis,” said Reshma Kewalramani, M.D., Chief Executive Officer and President of Vertex. “Our north star for more than 20 years has been to address the underlying cause of cystic fibrosis, treat more people with this disease, and bring more people to normal le
Vertex Announces U.S. FDA Approval for TRIKAFTA (elexacaftor/tezacaftor/ivacaftor and ivacaftor) to Include Additional Non- F508del TRIKAFTA-Responsive Variants20.12.2024 21:35:00 CET | Press Release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the U.S. Food and Drug Administration (FDA) has approved the expanded use of TRIKAFTA® (elexacaftor/tezacaftor/ivacaftor and ivacaftor) for the treatment of people with cystic fibrosis (CF) ages 2 and older who have at least one F508del mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene or a mutation that is responsive to TRIKAFTA based on clinical and/or in vitro data. In addition, safety information on liver injury and liver failure has been updated from warnings and precautions to a boxed warning. With this approval, 94 additional non-F508delCFTR mutations have been added to the TRIKAFTA label, and approximately 300 additional people with CF in the U.S. are now eligible for a medicine to treat the underlying cause of their disease for the first time. “Since its first approval in 2019, TRIKAFTA has had a transformative impact on tens of thousands of people living with cystic fibrosis,” sai
HSBC Continental Europe Enters Into a Memorandum of Understanding Regarding Potential Sale of HSBC Assurances Vie (France) to Matmut Société d’Assurance Mutuelle20.12.2024 20:32:00 CET | Press Release
Regulatory News: HSBC Continental Europe has signed a Memorandum of Understanding (‘MOU‘) regarding the potential sale of its French life insurance business, HSBC Assurances Vie (France), to Matmut Société d’Assurance Mutuelle (‘Matmut’) (the “Potential Transaction”). HSBC Assurances Vie (France) provides a wide range of life insurance solutions and services, with over 20 billion euros of outstanding assets, net income1 of 77 million euros and a Solvency II ratio of 287% in 2023. As part of the Potential Transaction, HSBC Continental Europe and Matmut would enter into a long-term arrangement for HSBC Global Asset Management (France) to continue to partner with HSBC Assurances Vie (France). HSBC Assurances Vie (France) will continue its existing distribution arrangements. The Potential Transaction would provide customers and employees of HSBC Insurance Life (France) with the opportunity to join one of the leading French mutual insurance groups, which is in full development, and forms pa
SBC Medical Group Co., Ltd. Sells Two Subsidiaries20.12.2024 13:00:00 CET | Press Release
On December 17, 2024, SBC Medical Group Holdings Incorporated (“SBC Medical”, or the “Company”), announced that its subsidiary, SBC Medical Group Co., Ltd. (hereinafter referred to as "SBCMG"), has decided to sell all shares of its subsidiaries, SBC Kijimadaira Resort Co., Ltd. (hereinafter referred to as "Kijimadaira") and Skynet Academy Co., Ltd. (hereinafter referred to as "SNA"), as outlined below. The decision to sell these subsidiaries was made to concentrate SBCMG's management resources on its core medical services business, in line with its strategy of prioritizing and focusing on key business areas. The subsidiaries being sold operate in the following industries: Kijimadaira: Ski resort operations SNA: Flight training operations The shares will be sold to a company wholly owned by Yoshiyuki Aikawa, the CEO of the Company. Since this transaction constitutes a related party transaction, it was deliberated and approved by the Company’s Board of Directors and Audit Committee. To e
Aarhus University: New Global Study Sheds Light on the Learning Crisis: Three Years After COVID-1920.12.2024 13:00:00 CET | Press Release
TIMSS 2023 has revealed an alarming global learning crisis exacerbated by the COVID-19 pandemic. Compared to the long term trend in progress in mathematics and science achievement has not only stalled but reversed when taking school closures into account, with the most vulnerable students facing the steepest losses. Key Findings Global Achievement Decline: A 0.11 standard deviation drop in student performance reflects the pandemic's lasting impact. Disproportionate Impact: Low performers, girls, and language minorities faced losses up to twice the average (0.22 standard deviations), deepening existing inequities. Regional Variations: Countries with prolonged school closures and limited remote learning resources experienced the steepest declines. Why This Matters School closures disrupted the education of over one billion children worldwide, with disadvantaged students suffering the most. “The widening gender gap in STEM fields is particularly troubling,” said Christian Kjeldsen, incomi
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom